Active substanceGlycineGlycine
Similar drugsTo uncover
  • Glycine
    pills n / az. 
    BIOTICS MNPK, LLC     Russia
  • Glycine
    pills n / az. 
    VERTEKS, AO     Russia
  • Glycine forte
    pills n / az. 
  • Glycine Fort Pharmaplant®
    pills n / az. 
  • Glycine-Bio Pharmaplant®
    pills n / az. 
    OZONE, LLC     Russia
  • Glycine-Canon
    pills n / az. 
  • Glycine-MCPP
    pills n / az. 
  • Dosage form: & nbspsublingual tablets
    Composition:

    1 tablet contains

    of the active substance: glycine 0.05 g and 0.1 g;

    Excipients: povidone (callidone 25), microcrystalline cellulose, magnesium stearate.

    Description:

    Tablets 0.05 g: white tablets with a facet on both sides.

    Tablets 0.1 g: tablets of white color with a risk on one side and a chamfer on both sides. Presence of marble is admissible.

    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    N.06.B.X   Other psychostimulants and nootropic drugs

    Pharmacodynamics:

    A replaceable amino acid, the central neurotransmitter of the inhibitory type of action. It improves the metabolic processes in the brain tissues, has an antidepressant and sedative effect. Has GABA-ergic, alpha 1-adrenergic blocking, antioxidant and antitoxic action; regulates the activity of glutamate (NMDA) receptors, due to which reduces psychoemotional tension, aggressiveness and conflict; improves social adaptation and mood; facilitates sleep and normalizes sleep; increases mental performance; reduces the severity of vegetative-vascular disorders (including in the climacteric period), reduces the toxic effect of ethanol on the central nervous system. Effective as an adjunct to epileptic seizures.

    Pharmacokinetics:Easily penetrates into most biological fluids and body tissues, including the brain, not cumulates. Rapidly destroyed in the liver by glycine oxidase to water and carbon dioxide.
    Indications:

    Stress states (including psychoemotional stress), decreased mental performance, deviant forms of behavior of children and adolescents, various functional and organic diseases of the nervous system, accompanied by increased excitability, emotional instability, decreased mental performance and sleep disturbances: neuroses, neurosis-like conditions, the consequences of neuroinfections and craniocerebral trauma, perinatal and other forms of encephalopathies (including alcoholic genesis).In narcology - as a drug that increases mental performance and reduces psychoemotional stress during remission in cases of encephalopathy, organic lesions of the central and peripheral nervous system.

    Contraindications:

    Hypersensitivity.

    Carefully:

    Arterial hypotension.

    Pregnancy and lactation:

    Maybe.

    Dosing and Administration:

    Sublingually or buccally on 100 mg (in tablets or as a powder after grinding the tablet).

    Practically healthy children, adolescents and adults with psychoemotional stresses, memory loss, attention, mental performance, mental retardation, deviant forms of behavior glycine is prescribed for 100 mg 2-3 times a day for 14-30 days.

    With functional and organic lesions of the nervous system, accompanied by increased excitability, emotional lability and sleep disturbance, children under 3 years of age are prescribed 50 mg 2-3 times a day for 7-14 days, then 50 mg once a day for 7-10 days. The daily dose is 100-150 mg, the course dose is 2-2.6 g.

    Children over 3 years and adults are prescribed 100 mg 2-3 times a day, the course of treatment is 7-14 days, it can be increased to 30 days, if necessary, the course is repeated after 30 days.

    If sleep disorders are prescribed for 20 minutes before bedtime or just before bedtime, 50-100 mg (depending on age).

    In narcology - 100 mg 2-3 times a day for 14-30 days. If necessary, the courses are repeated 4-6 times a year.

    Side effects:Allergic reactions.
    Interaction:

    It reduces the severity of side effects of antipsychotic drugs (antipsychotics), anxiolytics, antidepressants, hypnotics and anticonvulsant drugs.

    Special instructions:

    In patients with hypotension, Glycine-Bio Pharmaplant® is taken in smaller doses and under the control of blood pressure, when it falls below the usual level of intake is terminated.

    Effect on the ability to drive transp. cf. and fur:

    When taking Glycine-Bio Pharmaplant®, caution should be exercised when driving vehicles and engaging in other potentially hazardous activities that require a high concentration of attention and speed of psychomotor reactions, taking into account the profile of side effects.

    Form release / dosage:

    Tablets, 0.05 g and 0.1 g.

    Packaging:

    For 10, 50 tablets per contour cell package.

    For 10, 30, 50 or 100 tablets in a polymer container for medicines or a bottle of glass. One container (vial) or 1, 3, 5 or 10 out-of-round cell packs, together with the instruction for use, is placed in a pack of cardboard.

    For 5, 10 or 20 containers (bottles) or 20, 30, 50 or 100 contour cell packs, together with the corresponding number of instructions for use, put in a box of cardboard (for hospitals).

    Storage conditions:

    Store in a dry, dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-001851
    Date of registration:27.12.2011 / 14.01.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:OZONE, LLC OZONE, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspOZONE LLC OZONE LLC Russia
    Information update date: & nbsp01.05.2017
    Illustrated instructions
      Instructions
      Up